VENTANA pan-TRK (EPR17341) Assay is intended for the immunohistochemical detection of the C-terminal region of the tropomyosin receptor kinase (TRK) proteins A, B and C, which is known to be conserved across wild-type and fusion proteins, in formalin-fixed, paraffin-embedded (FFPE) neoplastic tissues stained with BenchMark IHC/ISH instruments.
Cancer:
Non Small Cell Lung Cancer, Solid Tumor
Gene:
NTRK (Neurotrophic receptor tyrosine kinase), NTRK1 (Neurotrophic tyrosine kinase, receptor, type 1), NTRK2 (Neurotrophic tyrosine kinase, receptor, type 2), NTRK3 (Neurotrophic tyrosine kinase, receptor, type 3)
NTRK (Neurotrophic receptor tyrosine kinase), NTRK1 (Neurotrophic tyrosine kinase, receptor, type 1), NTRK2 (Neurotrophic tyrosine kinase, receptor, type 2), NTRK3 (Neurotrophic tyrosine kinase, receptor, type 3)